University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania
Emily Largent (she/her) is an associate professor and chief of the Division of Medical Ethics at the University of Pennsylvania Perelman School of Medicine. She holds the Emanuel and Robert Hart Chair in Bioethics. She holds a secondary appointment at Penn Law, is a Senior Fellow at the Leonard Davis Institute of Health Economics, and is affiliated with the Center for Health Incentives and Behavioral Economics.
Dr. Largent’s work explores ethical and regulatory aspects of human subjects research as well the social, legal, and ethical, and clinical considerations that arise when research findings are translated into care. She has a particular focus on neurodegenerative diseases, including Alzheimer’s disease. Her work is supported by grant awards from the National Institute on Aging. Dr. Largent is a member of the Greenwall Faculty Scholars Program Class of 2023. She was the 2023 recipient of the Baruch A. Brody Award & Lecture in Bioethics and is an elected fellow of the Hastings Center. Her work has been published in leading bioethics and biomedical journals, including The Hastings Center Report, American Journal of Bioethics, New England Journal of Medicine, and JAMA. She co-authored Clinical Research Ethics Consultation: A Casebook (Oxford University Press).
Dr. Largent studied Science, Technology, and International Affairs as an undergraduate at Georgetown University and earned a second degree in nursing from Penn Nursing. She received her PhD in Health Policy, with a concentration in ethics, from Harvard University and her JD from Harvard Law School. Dr. Largent was previously a fellow in the Department of Bioethics at the National Institutes of Health (2008-2010) and clerked for Chief Judge Jeffrey Howard of the United States Court of Appeals for the First Circuit (2016-2017).
Friday, September 20, 2024
10:15 AM – 11:15 AM CT
The Ethics of Patient and Public Engagement in Drug Development, Approval, and Access
Saturday, September 21, 2024
8:45 AM – 9:45 AM CT